What is the difference between covert and overt hepatic encephalopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hepatic Encephalopathy Classification The main difference between covert and overt hepatic encephalopathy is the severity of the symptoms, with covert HE being characterized by minor or no signs/symptoms but abnormalities on neuropsychological and/or neurophysiological tests, whereas overt HE is defined as the occurrence of disorientation, flapping tremor, or asterixis, corresponding to West Haven criteria grades II-IV 1.

Key Characteristics of Covert and Overt HE

  • Covert HE:
    • Minimal or no clinical signs of HE
    • Abnormalities detected only by neuropsychological and/or neurophysiological tests
    • Includes minimal and grade 1 HE, according to the West Haven criteria
  • Overt HE:
    • Presence of disorientation, flapping tremor, or asterixis
    • Corresponds to West Haven criteria grades II-IV
    • Can be further classified as episodic, recurrent, or persistent

Diagnosis and Classification

The diagnosis of HE should be based on the severity of the underlying liver disease, the severity and time course of mental alterations, and any identified precipitating events 1. The West Haven criteria are commonly used to classify the severity of HE, with covert HE corresponding to grades 0-1 and overt HE corresponding to grades II-IV 1.

Importance of Accurate Diagnosis

Accurate diagnosis and classification of HE are crucial for determining the appropriate treatment and management strategy, as well as for predicting patient outcomes 1. The presence of covert HE is an independent risk factor for the development of overt HE, and early detection and treatment can help prevent progression and improve patient outcomes 1.

Challenges in Diagnosis

The diagnosis of covert HE can be challenging due to the lack of specific clinical signs and the need for specialized testing, such as neuropsychological and neurophysiological tests 1. Additionally, the differential diagnosis of covert HE includes other conditions, such as mild cognitive impairment, which can present with similar symptoms 1.

Clinical Implications

In clinical practice, it is essential to be aware of the differences between covert and overt HE and to use a combination of clinical evaluation, laboratory tests, and specialized testing to diagnose and classify HE accurately 1. Early detection and treatment of covert HE can help prevent progression to overt HE and improve patient outcomes, highlighting the importance of regular screening and monitoring of patients with liver disease 1.

From the Research

Difference between Covert and Overt Hepatic Encephalopathy

There are no research papers provided to directly answer the question about the difference between covert and overt hepatic encephalopathy. The studies provided focus on the ethical considerations of covert administration of medication, particularly in patients with dementia or severe mental illness 2, 3, 4, 5, 6.

Covert Administration of Medication

  • The practice of covert administration of medication is a complex and contentious issue, with some scholars arguing that it is never acceptable due to the inherent wrongness of deception 2, 3.
  • Others believe that deception may be necessary in certain situations, such as when a patient lacks the competence to give informed consent 3, 4.
  • The administration of medication in food and drink, including covert medication, is a relatively common practice in institutional and homecare contexts 4, 5, 6.
  • However, this practice raises significant ethical concerns, including the risk of losing trust in caregivers and food, and the potential for therapeutic relationships to be jeopardized 5.

Documentation and Policy

  • The documentation of covert medication administration is often poor, with many institutions lacking a formal policy on the matter 4, 6.
  • It is essential to discuss the matter with the multidisciplinary team and, where appropriate, with the patient's relatives before administering medication covertly 4.
  • Supporting documentation should be completed to avoid medico-legal difficulties 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.